NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

The Nordic Bifurcation Study III

CompletedNA

Sponsor: Evald Hoej Christiansen

Conditions: Coronary Artery Disease

Interventions: Percutaneous coronary intervention (PCI)

Countries: Denmark

Should we, or should we not, perform dilatation of the side branch through the main vessel stent, if there is acceptable blood flow in the side branch?

Eligibility overview

Sex: ALL

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Stable or unstable angina pectoris. -Bifurcation lesion of "LAD/diagonal", "Cx/obtuse marginal", "RCA--
* PDA/posterola¬te¬ral branch" or "LM/Cx/LAD".
* Diameter of main vessel by visual estimate \> 2.5 mm.
* Diameter of side branch by visual estimate \> 2.25 mm.
* Signed informed consent

Exclusion Criteria:

* Age \< 18 years.
* ST-elevation infarction within 24 hours.
* Expected survival \< 1 year.
* S-creatinine \> 200 µmol/l.
* Allergy to Aspirin, Clopidogrel or Ticlopidine.
* Allergy to Sirolimus.

Locations (1)

Aarhus, Denmark